IMBRIANO, Carol
 Distribuzione geografica
Continente #
NA - Nord America 14.200
AS - Asia 6.447
EU - Europa 6.035
SA - Sud America 954
Continente sconosciuto - Info sul continente non disponibili 209
AF - Africa 153
OC - Oceania 81
Totale 28.079
Nazione #
US - Stati Uniti d'America 13.794
IT - Italia 2.126
SG - Singapore 2.024
CN - Cina 1.622
GB - Regno Unito 1.284
HK - Hong Kong 773
BR - Brasile 720
VN - Vietnam 699
SE - Svezia 654
DE - Germania 400
BD - Bangladesh 335
FR - Francia 292
RU - Federazione Russa 247
FI - Finlandia 239
KR - Corea 183
UA - Ucraina 176
IN - India 169
CA - Canada 165
ID - Indonesia 125
TR - Turchia 115
JP - Giappone 96
MX - Messico 93
NL - Olanda 87
AR - Argentina 85
AU - Australia 80
BG - Bulgaria 73
ES - Italia 72
CZ - Repubblica Ceca 64
BE - Belgio 51
ZA - Sudafrica 50
PL - Polonia 49
IE - Irlanda 45
LT - Lituania 43
IQ - Iraq 41
EC - Ecuador 38
CO - Colombia 33
CR - Costa Rica 30
AE - Emirati Arabi Uniti 28
AT - Austria 27
MY - Malesia 25
PK - Pakistan 25
UZ - Uzbekistan 25
EG - Egitto 22
MA - Marocco 22
CH - Svizzera 20
SA - Arabia Saudita 20
CL - Cile 19
PH - Filippine 19
VE - Venezuela 17
IL - Israele 16
PY - Paraguay 15
TW - Taiwan 15
HN - Honduras 14
TT - Trinidad e Tobago 14
UY - Uruguay 14
SV - El Salvador 13
CW - ???statistics.table.value.countryCode.CW??? 12
GT - Guatemala 12
NI - Nicaragua 12
TH - Thailandia 12
TN - Tunisia 12
DZ - Algeria 11
JM - Giamaica 11
IR - Iran 10
NP - Nepal 10
PT - Portogallo 10
ET - Etiopia 9
JO - Giordania 9
KE - Kenya 9
LB - Libano 9
PE - Perù 9
PR - Porto Rico 9
AL - Albania 8
RS - Serbia 8
GP - Guadalupe 7
GR - Grecia 7
RO - Romania 7
BB - Barbados 6
EE - Estonia 6
SC - Seychelles 6
SI - Slovenia 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
PA - Panama 5
SN - Senegal 5
AM - Armenia 4
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
KZ - Kazakistan 4
LV - Lettonia 4
BH - Bahrain 3
BO - Bolivia 3
BZ - Belize 3
CI - Costa d'Avorio 3
EU - Europa 3
KG - Kirghizistan 3
KW - Kuwait 3
Totale 27.844
Città #
Ashburn 1.767
Singapore 1.236
Santa Clara 1.153
Fairfield 1.059
Southend 758
San Jose 751
Hong Kong 747
Woodbridge 658
Chandler 594
Council Bluffs 540
Hefei 512
Houston 452
Seattle 395
Ann Arbor 384
Modena 384
Cambridge 356
Wilmington 345
Nyköping 303
Jacksonville 296
Beijing 283
Los Angeles 262
Dearborn 256
New York 230
London 229
Ho Chi Minh City 215
Milan 207
Bologna 180
Hanoi 172
The Dalles 168
Seoul 164
Chicago 146
Helsinki 138
San Diego 105
Jakarta 95
Reggio Emilia 91
Austin 81
Munich 81
Lauterbourg 79
Dallas 76
Shanghai 75
Moscow 74
Tokyo 73
Buffalo 72
Princeton 71
São Paulo 71
Sofia 67
Phoenix 64
Columbus 59
Eugene 59
Parma 59
Rome 54
Izmir 53
Bremen 51
Orem 50
Round Rock 50
Brno 45
Dong Ket 45
Salt Lake City 45
Atlanta 43
Fremont 43
Brussels 41
Mexico City 41
Warsaw 41
Boardman 40
Montreal 40
Denver 39
Turku 38
Da Nang 37
Brooklyn 36
Frankfurt am Main 36
Naples 35
Dublin 34
Toronto 34
Poplar 32
Durham 29
Johannesburg 29
Redwood City 29
Chennai 28
Formigine 27
Mumbai 27
Stockholm 27
Kent 26
San Francisco 26
Turin 26
Paris 25
Tampa 25
Amsterdam 24
Des Moines 24
Falls Church 24
Rio de Janeiro 24
San José 24
Tashkent 24
Elk Grove Village 23
Haiphong 23
Baghdad 22
Norwalk 22
Nuremberg 22
Washington 22
Brasília 21
Belo Horizonte 20
Totale 18.338
Nome #
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 606
Dynamic Phosphorylation of the Myocyte Enhancer Factor 2Cα1 Splice Variant Promotes Skeletal Muscle Regeneration and Hypertrophy 471
Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters 463
An autoregulatory loop controls the expression of the transcription factor NF-Y 446
Potent Anti-Cancer Properties of Phthalimide-Based Curcumin Derivatives on Prostate Tumor Cells 436
NF-Y splice variants differentially affect skeletal myogenesis 428
NF-YA splice variants have different roles on muscle differentiation 428
Curcumin derivatives and Aβ-fibrillar aggregates: An interactions’ study for diagnostic/therapeutic purposes in neurodegenerative diseases 426
Newly synthesized curcumin derivatives: crosstalk between chemico-physical properties and biological activity. 423
Phosphorylation and alternative splicing of MEF2C, a dual switch function in muscle regeneration 416
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 402
Curcumin derivatives: molecular basis of their anti-cancer activity. 401
Direct non transcriptional role of NF-Y in DNA replication 401
Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells 397
Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters 395
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 394
bis-Dehydroxy-Curcumin Triggers Mitochondrial-Associated Cell Death in Human Colon Cancer Cells through ER-Stress Induced Autophagy. 385
NF-Y recruitment of TFIID, multiple interactions with histone fold TAF(II)s 383
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 383
NF-Y activates genes of metabolic pathways altered in cancer cells 371
The NF-Y/p53 liaison: Well beyond repression. 369
Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2 367
New curcumin-derived ligands and their affinity towards Ga3+, Fe3+and Cu2+: Spectroscopic studies on complex formation and stability in solution 364
HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes 363
Cloning and characterization of the histone-fold proteins YBL1 and YCL1 363
Dissection of the NF-Y transcriptional activation potential 362
Alternative splicing of transcription factors genes in muscle physiology and pathology 362
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 359
Structure-Based Design of Potent Aromatase Inhibitors by High-Throughput Docking 358
NF-Y co-associates with FOS at promoters, enhancers, repetitive elements, and inactive chromatin regions, and is stereo-positioned with growth-controlling transcription factors. 357
NF-Y loss triggers p53 stabilization and apoptosis in HPV18-positive cells by affecting E6 transcription 347
Ternary complex formation between MADS-box transcription factors and the histone fold protein NF-YB 344
Alternative splicing of the transcription factor NF-Y promotes cell migration and invasion in colon cancer 340
An acetylation-mono-ubiquitination switch on lysine 120 of H2B 338
Dysregulation of NF–Y splicing drives metabolic rewiring and aggressiveness in colon cancer 336
The interplay between NF-Y, AR and lipid metabolism regulates tumor aggressiveness in prostate cancer. 335
Gain-of-function p53 mutants have widespread genomic locations partially overlapping with p63 335
DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters via p53 C-terminal lysines 333
Switch of NF-YA splice variants in prostate cancer development and progression 333
A specific role for the splice variants of the transcription factor NF-Y in modulating the transcriptional activity of the myogenic program 332
The 1,10-phenanthroline ligand enhances the antiproliferative activity of dna-intercalating thiourea-pd(Ii) and-pt(ii) complexes against cisplatin-sensitive and-resistant human ovarian cancer cell lines 332
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 329
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 323
Specific inhibition of NF-Y subunits triggers different cell proliferation defects. 322
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 306
Probing solute–solvent hydrogen bonding with fluorescent water-soluble curcuminoids 305
NF-Y LOSS REACTIVATES p53 AND TRIGGERS p53-DEPENDENT APOPTOSIS IN HPV-POSITIVE HUMAN CERVICAL CARCINOMA CELLS 302
Alterations in NF-Y splicing enable the metabolic plasticity of colon cancer cells and foster dynamic interactions within the tumor niche 301
A non transcriptional role for NF-Y in DNA replication 300
Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads 296
Role of the CCAAT-transcription factor NF-Y and its splice variants in myogenic differentiation and muscle regeneration 290
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 287
NF-YC complexity is generated by dual promoters and alternative splicing 287
Development of new metal-chelating multi target drus derived from Curcumin 285
Dynamic recruitment of transcription factors and epigenetic changes on the ER stress response gene promoters 282
The transcription factor NF-Y participates to stem cell fate decision and regeneration in adult skeletal muscle 281
Direct non transcriptional role of the CCAAT-factor NF-Y in DNA replication 279
The NF-YA splicing signature controls aggressiveness of colon cancer by regulating different modes of cell migration and cell metabolism. 279
Role of the transcriprion factor NF-Y in cell cycle regulation 276
Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates 273
The NF-YA Splicing Signature Controls Aggressiveness of Colon Cancer by Regulating Cell Metabolism and Different Types of Cell Migration 272
Development of new therapeutic Metal(III)-chelating agents derived from Curcumin 272
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 267
Monitoring DNA Hybridization with Organic Electrochemical Transistors Functionalized with Polydopamine 267
The transcription factor NF-Y is required for satellite stem cell proliferation and skeletal muscle tissue repair 265
Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex 261
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 257
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 257
Development of Stable Amino-Pyrimidine–Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity 247
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 243
DNA damage promotes HDAC4 nuclear localization and G2/M promoters repression via p53 C-terminal lysisnes 239
Development of new metal-based phyto-radiopharmaceuticals: diagnostic agents derived from Cur(e)cumin 238
Understanding the molecular mechanisms of Curcumin derivatives chemotherapic activity 236
Investigation of transcription factor–DNA binding with electrolyte-gated organic transistors 230
Expression of the CCAAT-binding factor NF-Y in Caenorhabditis elegans 228
In situ immunofluorescent staining of autophagy in muscle stem cells 220
Cell cycle regulation of NF-YC nuclear localization 218
Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism 202
Deciphering the transcriptional network of NF-Y in prostate cancer development and progression 198
Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives 194
Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation 182
Histone Marks-Dependent Effect on Alternative Splicing: New Perspectives for Targeted Splicing Modulation in Cancer? 168
The transcription factor NF-Y participates in prostate cancer progression and response to androgen-deprivation therapy 167
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 163
Cross-talk between NF-Y transcription factor and m6A epitanscriptomic regulators in colon cancer: molecular characterization and clinical relevance. 155
The transcription factor NF-Y is required for satellite stem cell myogenic progression and skeletal muscle tissue repair 153
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function 141
The NF–Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer 141
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 131
Metabolic reprogramming controlled by NF-YA alternative splicing creates therapeutic opportunities in colorectal cancer 126
Correction: Investigation of transcription factor-DNA binding with electrolyte-gated organic transistors (J. Mater. Chem. C (2024) 12 (7596–7604) DOI: 10.1039/D4TC00260A) 122
The role(s) of NF-Y in development and differentiation 117
MXene‐Based Conductive Micropatterned Composites Promote Myogenic Differentiation of Muscle Cells 56
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer 55
null 4
Totale 28.079
Categoria #
all - tutte 98.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.159 0 0 0 0 75 111 101 72 202 135 297 166
2022/20231.960 199 260 125 173 202 246 56 182 204 52 153 108
2023/20241.647 60 75 101 151 295 133 244 135 28 65 135 225
2024/20254.889 146 54 203 323 880 759 434 297 469 271 500 553
2025/20268.823 610 385 684 1.068 1.365 589 1.006 391 855 860 537 473
2026/20272.726 289 578 772 906 181 0 0 0 0 0 0 0
Totale 28.079